Pepscope

About:

PEPSCOPE aims to make protein kinase inhibitors better therapeutics by providing unique insights in their functioning.

Website: https://kinomeactivity.com/

Top Investors: Netherlands Enterprise Agency, OostNL, KIKK Capital

Description:

Pepscope is a Dutch biotechnology company offering innovative endogenous protein kinase activity profiling technologies.

Total Funding Amount:

4.3M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Utrecht, Utrecht, The Netherlands

Founded Date:

2012-06-07

Contact Email:

info(AT)pepscope.com

Founders:

Anna Ressa, Hans Brouwer

Number of Employees:

1-10

Last Funding Date:

2020-12-14

IPO Status:

Private

Industries: